Association Between the Dihydrotestosterone Level in the Prostate and Prostate Cancer Aggressiveness Using the Gleason Score
Abstract
Purpose:
To our knowledge the association between dihydrotestosterone in the prostate and prostate cancer aggressiveness has not yet been elucidated. We analyzed dihydrotestosterone levels in the prostate and Gleason score in patients diagnosed with clinically localized prostate cancer.
Materials and Methods:
A total of 81 patients with suspected prostate cancer underwent prostate biopsy. Serum samples were collected before biopsy. Dihydrotestosterone levels in prostatic tissue and serum were analyzed using liquid chromatography/electrospray ionization-mass spectrometry after polar derivatization.
Results:
A total of 47 patients were diagnosed with stages T1 to T3N0M0 prostate cancer and 34 were diagnosed with no malignancy. Of the 47 patients 32 had a Gleason score of 6 or less and 15 had a score of 7 to 10. Dihydrotestosterone in prostatic tissue in patients with Gleason score 7 to 10 disease was significantly lower than in those with Gleason score 6 or less disease (p = 0.025). Gleason score correlated with the testosterone-to-serum dihydrotestosterone ratio (rs = 0.329, p = 0.038).
Conclusions:
Patients with Gleason score 7 to 10 prostate cancer have low dihydrotestosterone in the prostate, although there were no significant differences between patients with Gleason score 7 to 10 vs 6 or less prostate cancer with respect to serum androgens. Low dihydrotestosterone in cases of aggressive prostate cancer is probably sufficient to activate androgen receptor expression and propagate tumor growth.
References
- 1 : 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA2005; 293: 2095. Google Scholar
- 2 : Occult prostate cancer in men with low serum testosterone levels. JAMA1996; 276: 1904. Crossref, Medline, Google Scholar
- 3 : Is low serum free testosterone a marker for high grade prostate cancer?. J Urol2000; 163: 824. Link, Google Scholar
- 4 : Association between prostate cancer and serum testosterone levels. Prostate2002; 53: 179. Google Scholar
- 5 : Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol2003; 169: 1670. Link, Google Scholar
- 6 : Testosterone as a predictor of pathological stage in clinically localized prostate cancer. J Urol2005; 173: 1935. Link, Google Scholar
- 7 : Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: hypogonadism represents bad prognosis in prostate cancer. J Urol2005; 174: 2178. Link, Google Scholar
- 8 : Serum testosterone—a significant determinant of metastatic relapse for irradiated localized prostate cancer. Urology1997; 49: 327. Crossref, Medline, Google Scholar
- 9 : No association of serum gonadal or pituitary hormones with prognostic parameters in stages T1 to T3 PN0M0 prostate cancer. J Urol2002; 168: 1188. Link, Google Scholar
- 10 : The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer. Clin Cancer Res2004; 10: 7121. Google Scholar
- 11 : Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma. Scand J Urol Nephrol Suppl1994; 157: 41. Google Scholar
- 12 : Influence of radical prostatectomy on serum hormone levels. J Urol1998; 160: 449. Link, Google Scholar
- 13 : On the prevention and therapy of prostate cancer by androgen administration. Cancer Res1999; 59: 4161. Google Scholar
- 14 : Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J Clin Oncol2005; 23: 7546. Google Scholar
- 15 : The influence of finasteride on the development of prostate cancer. N Engl J Med2003; 349: 215. Google Scholar
- 16 : The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge. J Urol2005; 174: 2098. Link, Google Scholar
- 17 : Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy. BJU Int2005; 95: 509. Google Scholar
- 18 : Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome. Urology2005; 66: 930. Google Scholar
- 19 : High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy. Am J Surg Pathol2004; 28: 928. Google Scholar
- 20 : Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease. Prostate2005; 63: 19. Google Scholar
